Hester Biosciences shareholders approve promoter reclassification
- Shareholders approved reclassifying two promoters as public shareholders
- Resolution passed with 99.99% assent via remote e-voting
- Mr. Ravin Gandhi and Ms. Bela Gandhi affected by the change
- Promoter group polled 77.42% of shares with full support

*this image is generated using AI for illustrative purposes only.
Hester Biosciences shareholders approved the reclassification of two promoter group members as public shareholders via a postal ballot. The ordinary resolution passed with 99.99% assent on September 4, 2026.
The company sought approval under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholders voted through remote e-voting between August 5 and September 3, 2026. Central Depository Services (India) Limited facilitated the voting process.
Voting Results
A total of 89 shareholders cast valid votes representing 3,981,963 shares. Two votes comprising 40,227 shares were declared invalid. The promoters and promoter group held no interest in the resolution.
| Category | Shares Held | Votes Polled | Votes in Favour | Votes Against |
|---|---|---|---|---|
| Promoter Group | 4,570,944 | 3,538,635 | 3,538,635 | - |
| Public Institutional | 31,483 | 11,414 | 11,253 | 161 |
| Public Others | 3,904,438 | 431,914 | 431,648 | 266 |
| Total | 8,506,865 | 3,981,963 | 3,981,536 | 427 |
Reclassification Details
The resolution affects Mr. Ravin Gandhi and Ms. Bela Gandhi. Both individuals hold less than 10% of the paid-up equity share capital and do not exercise control over the company. They are not represented on the Board of Directors or as key managerial personnel.
Mr. Ravin Gandhi holds 403,320 shares (4.74% of paid-up capital). Ms. Bela Gandhi holds 400,635 shares (4.71% of paid-up capital). The outgoing promoters confirmed they are not willful defaulters or fugitive economic offenders.
What the Numbers Show
The promoter group demonstrated high engagement, polling 77.42% of their outstanding shares with unanimous support for the reclassification. In contrast, public institutional holders showed lower participation at 36.25%, while public retail participation stood at 11.06%.
Historical Stock Returns for Hester Biosciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.88% | +2.63% | -4.12% | +57.27% | +8.90% | -1.56% |
How will the reclassification of Ravin and Bela Gandhi as public shareholders impact Hester Biosciences' promoter holding percentage and future dilution norms under SEBI regulations?
Given the low retail participation rate of 11.06%, what strategies might the company employ to improve minority shareholder engagement in future corporate actions?
Could this reclassification signal a broader shift in ownership structure that might pave the way for potential divestment or liquidity events for the Gandhi family?


































